Navigation Links
Disease in Medical Technology

Scientists Discover Origin of Malaria

... chimps that had died due to anthrax, respiratory disease or other reasons in the Tai National Park. ... Amherst. "It is now clear that a new disease that successfully jumps from an animal to a human ... said. "This makes the task of stopping future disease spillovers from animals to humans vital, not only ...

Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on Interactions With FDA

... this quarter. Background on Gaucher disease Gaucher disease is an autosomal recessive disease and the most prevalent Lysosomal Storage Disorder ...

Online H1N1 Management: FairChoice Helps Schools Respond to Infectious Disease on Campus

... campus health officers to alert students about disease prevention, monitor the spread of infection, and ... to distribute information about meningococcal disease and vaccination to students. Since its ... have certified their receipt of meningococcal disease information online, according to the Columbia ...

VisEn Molecular Imaging Technology Enables Key Insights Into Newly Discovered Biologic Pathway Published in SCIENCE

... potentially advance therapeutic approaches to key disease areas including inflammation and myocardial ... of the recruited splenic monocytes at the disease site, thus helping to confirm "unambiguously the ... characterizing and quantifying ranges of disease biomarkers and therapeutic efficacy in vivo . ...

Study Shows Cancer Vaccines Led to Long-Term Survival for Patients with Metastatic Melanoma and to Long Periods of Disease Control After Completion of Therapy

... rates in patients with metastatic melanoma whose disease had been minimized by other therapies. ... patients with recurrent or distant metastatic disease at the time of diagnosis because there are no ... therapy, even though they had widely metastatic disease and/or repeated appearance of new metastases ...

Economy is Driving Many Osteoporotic Women to Retire Later - But Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease

... the number of women suffering from the disease is predicted to increase in Ohio by more than 22 ... osteoporosis are not optimally managing their disease despite the need and desire to work longer, ... half of the women with PMO are fearful that the disease will limit their ability to work. However, the ...

Dirucotide Does Not Meet Primary Endpoint in Phase III MAESTRO-01 Trial in Secondary Progressive Multiple Sclerosis

... did not meet the primary endpoint of delaying disease progression, as measured by the Expanded ... (MS) is a chronic, progressive, often disabling disease that attacks the central nervous system(ii). MS ... 400,000 in the United States(v). It is a disease that affects more women than men, with onset ...

R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies - Results Incongruent

... physician and patient global assessment of disease activity, patient reported pain score, and any ... people in the U.S. It is a chronic inflammatory disease that puts the body's immune system into overdrive ... pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in ...

Researchers Create First Targeted Knockout Rats Using Zinc Finger Nuclease Technology

... knockout rats to gain a better understanding of disease processes related to hypertension, heart disease, ... pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other ... neuropathic pain, nerve regeneration, Parkinson's disease and monogenic diseases. Sangamo's core ...

Schering-Plough Announces U.S. Filing of Mometasone Furoate/Formoterol Fumarate Combination for the Maintenance Treatment of Asthma

... for asthma and chronic obstructive pulmonary disease (COPD) medications, in terms of dollar sales (1). ... About Asthma Asthma is a chronic lung disease characterized by inflammation of the air ... and costly chronic diseases.(2) Annually, this disease leads to almost two million asthma-related ...

Exenatide Once Weekly Provided Superior Glucose Control Compared to Lantus(R) in Head-to-Head DURATION-3 Study

... Diabetes is the fifth leading cause of death by disease in the U.S. and results in approximately $174 ... According to the Centers for disease Control and Prevention's National Health and ... CC. "Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes." ...

Northern California Cancer Center's First-of-Its-Kind Research Reveals Low Socioeconomic Status Often Equals Poor Chance of Lymphoma Survival

... to address waxing and waning progression of disease FREMONT, Calif., July 20 ... of race/ethnicity, or the stage of their disease when diagnosed. The study results were published ... a continuing care program. The nature of the disease could make it difficult for people who may not be ...

Cardax Pharmaceuticals Nominates Clinical Candidate Heptax for Liver Disease; Heptax Ameliorates Inflammation and Oxidative Stress Related to Liver Disease and Metabolic Syndrome

... Hawaii, July 20 /PRNewswire/ -- The Centers for disease Control and Prevention reported this week that ... syndrome, including liver and cardiovascular disease as well as diabetes. Preclinical animal studies ... for the treatment of liver and cardiovascular disease as well as metabolic syndrome." "Our ...

First Potential Lupus-Specific Treatment in Sight

... treated with BENLYSTA had improvement in overall disease activity without clinically significant flare-ups ... provide hope that this complex chronic autoimmune disease can be brought under control and that, ... developed to specifically treat lupus since the disease was discovered more than a century ago. ...

Lupus Research Institute Highly Encouraged by Benlysta(TM) Trial Results

... that enables researchers to demonstrate disease improvement. This will benefit lupus patients and ... currently used treatments are as toxic as the disease itself. Lupus is a leading cause of premature cardiovascular disease, kidney disease and stroke among young women. About ...

Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus

... effect on both patients living with the disease and their families," said Carlo Russo, M.D., ... BENLYSTA also significantly reduced SLE disease activity versus placebo based on a number of ... of at least 4 points on the SELENA SLEDAI disease activity scale (which indicates a clinically ...

Cognition Therapeutics Closes Series A Financing to Advance Drug Candidates for Alzheimer's Disease

... approach to treat or prevent Alzheimer's disease by targeting the proteins that cause the earliest ... senior advisor to Ogden CAP. "Alzheimer's disease is a major health epidemic that places increasing ... disease," Gailus continued. Alzheimer's disease affects an estimated four and a half million ...

Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease

... accepted would allow physicians to treat Gaucher disease patients with velaglucerase alfa on an early ... pattern. Background on Gaucher disease Gaucher disease is an autosomal ...

Mayo Clinic Study Finds Earliest Evidence of Memory Decline in Middle-Aged People at Genetic Risk for Alzheimer's Disease

... a source of worry for many who fear Alzheimer's disease . Now a new Mayo Clinic-led study published in ... of a common genetic risk factor for Alzheimer's disease begin to have memory declines in their mid-50s, ... genetic risk factor for developing Alzheimer's disease at older ages. Each additional copy of this gene ...

Results From Drug Trials and New Risk Factors Announced at International Alzheimer's Conference

... epidemic of the 21st century -- Alzheimer's disease -- at the Alzheimer's Association 2009 International Conference on Alzheimer's disease (ICAD 2009) in Vienna, Austria. (Logo: ... mild to moderate Alzheimer's by the Alzheimer's disease Cooperative Study (ADCS) supported by the U.S. ...

Michael J. Fox Foundation Awards Over $2 Million for Validation of 10 Parkinson's Therapeutic Targets

... pathway, as a target for Parkinson ' s disease therapy Yoon-Seong Kim, MD, PhD, Weill ... strategy for the t reatment of Parkinson's disease Deniz Kirik, MD, PhD, Lund University ... as therapeutic targets for Parkinson ' s disease Hilal A. Lashuel, PhD, and Patrick ...

deCODE Discovers Second Common Genetic Risk Factor for Atrial Fibrillation and Stroke

... public health challenges from cardiovascular disease to cancer. Based upon these discoveries deCODE ... with therapeutic applications in Alzheimer's disease and other conditions. deCODE is delivering on the ... personal genome analysis service and new focused disease scans, integrating the genetic variants included ...

PTSD Associated With Higher Alzheimer's/Dementia Risk; Moderate Alcohol Consumption May Lower it

... -- Though discoveries about Alzheimer's disease risk factors are often in the news, adults do not know about the relationship between Alzheimer's disease risk and heart health, nor that physical activity ... 2009 International Conference on Alzheimer's disease (ICAD 2009) in Vienna. (Logo: ...

Results From Trials of DHA in Alzheimer's Disease and Age-Related Cognitive Decline

... 2009 International Conference on Alzheimer's disease (ICAD 2009) in Vienna. (Logo: ... of the trials was conducted by the Alzheimer's disease Cooperative Study (ADCS) supported by the ... for Alzheimer's must be given very early in the disease for them to be truly effective," said William ...

CEL-SCI to Present Data from Multikine Clinical Trials at National Institutes of Health (NIH), National Cancer Institute (NCI) Seminar Series

... that Multikine treatment provides for early disease management in newly diagnosed (treatment naive) ... of the Head and Neck. Early intervention in this disease is seen by many clinicians and researchers in the field as a key to improving disease outcome in these patients. Dr. Talor will ...

Rigel's R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial

... a treatment failure (ACR non-responder). disease Activity Scores are based on a 28 joint ... physician and patient global assessment of disease activity, patient reported pain score, and any ... the ACR 20, ACR 50 and ACR 70 scores, as well as disease Activity Scores (DAS) over the period of 6 ....

Thiarabine Demonstrates a Reduction of Both Inflammatory and Erosive Disease Parameters in Rheumatoid Arthritis

... treatment resulted in a broad inhibition of disease pathology, with reduction of both inflammatory and erosive disease parameters, as well as protection from loss of ... thiarabine blocked the development of joint disease at the 60 mg/kg/day dose level and exhibited a ...

Clay Walker's Band Against MS Foundation Donates $150,000 To Support Multiple Sclerosis Research

... The money will fund important studies on the disease and potential cures at the University of Texas ... also to the millions of people who live with the disease on a daily basis," said Dr. Wolinsky. "We are ... he wanted to help others living with the same disease he has battled since 1996. More information about ...

Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease

... approved and marketed treatment for Gaucher disease patients, it has filed a treatment protocol for ... protocol would allow physicians to treat Gaucher disease patients with velaglucerase alfa ahead of ... alfa as an alternative choice for Gaucher disease patients. Background on ...

Number of Patients With Dementia on the Rise

... Sid Gilman, M.D., director of the Alzheimer's disease Research Center at University of Michigan ... and others in her community. "It's a horrible disease that robs people of their humanity. They forget ... the current number of patients with Alzheimer's disease in the United States is roughly 5 million. By the ...

deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia

... are crucial for teasing out the biology of the disease and making it possible for us to begin to ... with therapeutic applications in Alzheimer's disease and other conditions. deCODE is a global leader ... public health challenges from cardiovascular disease to cancer. Based upon these discoveries deCODE ...

MedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants

... regions established by the U.S. Centers for disease Control & Prevention. Additionally, this ... prematurely as well as those with chronic lung disease (CLD) or congenital heart disease (CHD) are at highest risk for ...

SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

... itself on being a leading provider of rheumatic disease therapies within the European rheumatology ... arthritis is a chronic and debilitating disease that affects more than three million people in ... arthritis, AS is a systemic inflammatory disease that, in addition to its effect on the spine, can ...

MJFF's Rapid Response Innovation Awards Hit Mid-2009 With Over $1 Million Funded in High-Risk/High-Reward Approaches to Parkinson's Disease

... and efficacy of an FDA-approved drug for kidney disease to treat Parkinson's; characterization of a ... for determining whether phenylbutyrate may slow disease progression. Richard Smeyne, PhD, of ... outbreak of 1918, documenting Parkinson's disease following exposure to flu virus. The researchers ...

ThromboGenics' Microplasmin Phase III Program Progressing According to Schedule

... Product for the Non-Surgical Treatment of Eye disease With No Reported Safety Issues ... innovative treatments for eye disease, vascular disease and cancer, announces today that its lead ... difference to the treatment of back of the eye disease and we very much look forward to reporting the ...

ALP Life Sciences, LLC Announces Nanoveson(TM) Patent Filing and Whitepaper Availability on Proposed Therapy for Non-Alcoholic Fatty Liver Disease (NAFLD) and Comorbid Diseases

... drug treatment for non-alcoholic fatty liver disease (NAFLD). Over 60 million adult Americans ... membranes are expected to be a rich source of disease state biomarkers. Nanoveson(TM) also has the ... therapeutic impact on arachidonic acid driven disease states by reducing arachidonic acid availability ...

Spherix Announces Positive Phase 2 Study Results

... Type 2 diabetes mellitus (T2DM) is a disease that is characterized by elevated blood glucose ... medications are usually needed as the disease progresses. There are an estimated 23.6 million ... increase as an epidemic. Customarily considered a disease of adults, T2DM is increasingly being diagnosed ...

Conatus Pharmaceuticals Initiates a Second Phase 2 Clinical Trial for the Treatment of Hepatitis

... a novel drug candidate for the treatment of liver disease associated with Hepatitis C Virus (HCV) ... multiple preclinical models of inflammatory liver disease and HCV infection. The clinical trial is a ... represents a novel approach to treating HCV disease and look forward to developing this drug ...

New Therapy Found to Prevent Heart Failure

... in heart failure or death in patients with heart disease who received an implanted cardiac ... were very positive. Patients with heart disease have a risk of arrhythmias and heart failure. The ... is a very large population of patients with heart disease who will benefit from this combined therapy." ...

GeoVax Labs, Inc. Announces Results of 2009 Annual Shareholders Meeting

... condoms. It is obvious from the spread of the disease that these methods are not adequate. Existing ... people to prevent Acquired Immunodeficiency disease (AIDS), caused by the virus known as HIV-1, ... Institutes of Health (NIH), The Centers for disease Control and Prevention (CDC) and GeoVax. ...
Other Contents
(Date:12/24/2014)...  Since its launch in December 2014, the ... eliminate the pain of trying to remember their usernames ... own biometrics fused to their smartphones. To assist people ... Hoyos Labs , the company that created 1U and ... offering the app for free. 1U is ...
(Date:12/22/2014)... 2014  NXT-ID, Inc. (NASDAQ: NXTD ... company focused on the growing mobile commerce market, announces ... Apollo Robbins for the 2015 International CES ... Apollo Robbins will be at the ... demonstrating some of his famous theft techniques to visiting ...
(Date:12/22/2014)... 22, 2014 Research and Markets ... addition of the "The Global Watermarking ... offering. http://photos.prnewswire.com/prnh/20130307/600769 ... overview of the global digital media watermarking ... and monitor piracy by securely and invisibly ...
Breaking Biology News(10 mins):1U Offers Best Solution to the Username / Password Dilemma: For FREE! 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 3NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 2NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 3NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 4The Global Watermarking and Fingerprinting Markets 2
(Date:12/24/2014)... Recently, iFitDress.com, a famous dress manufacturer and retailer, ... . All these items are brand new; they are made ... updated with the new range of high quality prom gowns. ... iFitDress.com’s designs are made according to the latest trends. For ... outfit from the company is handpicked by skilled tailors. , ...
(Date:12/24/2014)... 24, 2014 The federal court ... the blood thinner caused life-threatening episodes of internal ... structure for the proceeding, Bernstein Liebhard LLP reports. ... Court plans to select lawyers to serve as ... on appointing a Plaintiffs’ Steering Committee, which will ...
(Date:12/24/2014)... (PRWEB) December 24, 2014 Mike ... sat down with Derek Fenwick, PT, MBA, GCS, ... that will stem from the passing of the ... (IMPACT Act). In this taping of the Infinicast, the ... XVIII of the Social Security Act to standardize post-acute ...
(Date:12/24/2014)... 24, 2014 (HealthDay News) -- Hepatitis C infection does not ... a new study. Treatment advances have made it possible ... develop memory and thinking problems, mood swings and other types ... It,s believed that long-term infections with other viruses -- ... the brain. One of the prime suspects has been the ...
(Date:12/24/2014)... HealthDay Reporter WEDNESDAY, Dec. ... to start smoking or drinking with each additional symptom ... disorder, new research suggests. "Our findings underscore ... substance use as [these] children approach adolescence," said study ... Research Group, which is part of Cincinnati Children,s Hospital. ...
Breaking Medicine News(10 mins):Health News:Many Prom Dresses under 150 from Well-known Dress Manufacturer iFitDress.com 2Health News:Court Overseeing Federal Xarelto Lawsuits Issues Coordination Order, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal Xarelto Lawsuits Issues Coordination Order, Bernstein Liebhard LLP Reports 3Health News:Latest Episode of Infinicast Features Infinity Rehab President Discussing IMPACT Act of 2014 and Changes for Post-Acute Therapy Providers in 2015 2Health News:Hepatitis C Infection Isn't Related to HIV Brain Woes: Study 2Health News:ADHD May Raise Teens' Odds for Smoking, Drinking 2Health News:ADHD May Raise Teens' Odds for Smoking, Drinking 3
Other TagsOther Tags